• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术前炎症相关预后评分对无症状原发肿瘤姑息性切除的 IV 期结直肠癌患者的预后价值。

Prognostic value of preoperative inflammation-based prognostic scores in patients with stage IV colorectal cancer who undergo palliative resection of asymptomatic primary tumors.

机构信息

Department of Surgical Oncology, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, Japan.

出版信息

Anticancer Res. 2013 Dec;33(12):5567-73.

PMID:24324099
Abstract

BACKGROUND

The need for palliative resection of asymptomatic primary tumor in patients with unresectable metastatic colorectal cancer (CRC) is still controversial. In order to identify predictors of survival after palliative resection, we investigated the correlations between clinicopathological factors, preoperative Glasgow prognostic score (GPS) and neutrophil-to-lymphocyte ratio (NLR), and survival.

PATIENTS AND METHODS

A total of 94 patients were enrolled in the present study. The prognostic value of the clinicopathological factors, GPS and NLR were analyzed retrospectively.

RESULTS

A multivariate analysis revealed that both the GPS and NLR were independent predictors of survival along with the preoperative Eastern Cooperative Oncology Group performance status (PS) and extent of distant metastasis. We classified the patients using a combination of these factors, and categorized them into three risk groups. The median survival time was five months in the high-risk group, compared to 21.5 months in the intermediate-risk group and 37 months in the low-risk group.

CONCLUSION

Sub-classification based on the GPS, NLR, PS and extent of distant metastasis can classify patients into three independent groups. There may be no survival benefits associated with palliative resection in the high-risk group.

摘要

背景

对于不可切除转移性结直肠癌(CRC)患者,无症状原发肿瘤的姑息性切除的需求仍存在争议。为了确定姑息性切除术后生存的预测因素,我们研究了临床病理因素、术前格拉斯哥预后评分(GPS)和中性粒细胞与淋巴细胞比值(NLR)与生存之间的相关性。

患者与方法

本研究共纳入 94 例患者。回顾性分析了临床病理因素、GPS 和 NLR 的预后价值。

结果

多因素分析显示,GPS 和 NLR 与术前东部肿瘤协作组表现状态(PS)和远处转移程度一起是生存的独立预测因素。我们结合这些因素对患者进行分类,并将其分为三个风险组。高危组的中位生存时间为 5 个月,中危组为 21.5 个月,低危组为 37 个月。

结论

基于 GPS、NLR、PS 和远处转移程度的亚分类可将患者分为三个独立的组。高危组姑息性切除可能没有生存获益。

相似文献

1
Prognostic value of preoperative inflammation-based prognostic scores in patients with stage IV colorectal cancer who undergo palliative resection of asymptomatic primary tumors.术前炎症相关预后评分对无症状原发肿瘤姑息性切除的 IV 期结直肠癌患者的预后价值。
Anticancer Res. 2013 Dec;33(12):5567-73.
2
The role of palliative resection for asymptomatic primary tumor in patients with unresectable stage IV colorectal cancer.姑息性切除在无法切除的IV期结直肠癌患者中对无症状原发性肿瘤的作用。
Dis Colon Rectum. 2014 Sep;57(9):1049-58. doi: 10.1097/DCR.0000000000000193.
3
Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.全身炎症标志物对不可切除转移性结直肠癌患者生存、化疗疗效预测及肿瘤进展监测的意义
Anticancer Res. 2015 Sep;35(9):5037-46.
4
A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer.术前中性粒细胞与淋巴细胞比值高与结直肠癌患者生存不良相关。
Anticancer Res. 2013 Aug;33(8):3291-4.
5
Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer.格拉斯哥预后评分作为结直肠癌根治性手术患者的预后因素。
Dig Surg. 2012;29(6):503-9. doi: 10.1159/000346002. Epub 2013 Feb 5.
6
[Significance of preoperative neutrophil-to-lymphocyte ratio as a predictor of prognosis in patients with stage IV colorectal cancer].[术前中性粒细胞与淋巴细胞比值作为IV期结直肠癌患者预后预测指标的意义]
Gan To Kagaku Ryoho. 2013 Nov;40(12):1603-5.
7
Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.基于炎症的预后系统预测术前癌胚抗原正常的结直肠癌患者的术后生存。
Ann Surg Oncol. 2012 Oct;19(11):3422-31. doi: 10.1245/s10434-012-2384-5. Epub 2012 May 11.
8
The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer.结直肠癌患者术后全身炎症反应的预后意义。
World J Surg Oncol. 2015 Jun 4;13:194. doi: 10.1186/s12957-015-0609-3.
9
Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer.比较两种不可切除的晚期胃癌患者基于炎症的预后评分。
Oncology. 2012;83(5):292-9. doi: 10.1159/000342376. Epub 2012 Sep 5.
10
Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival.晚期结直肠癌患者营养与炎症状态评估及其与生存的相关性
Nutr Cancer. 2006;55(1):78-85. doi: 10.1207/s15327914nc5501_10.

引用本文的文献

1
Definition of Palliative Surgery in Cancer Care: A Systematic Review.癌症护理中姑息性手术的定义:一项系统综述
J Surg Oncol. 2024 Nov 28. doi: 10.1002/jso.28016.
2
Association between inflammation-based prognostic markers and mortality after hip replacement.炎症标志物与髋关节置换术后死亡率的关系。
Sci Rep. 2024 Apr 23;14(1):9263. doi: 10.1038/s41598-024-58646-y.
3
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab.炎症指标作为接受化疗加贝伐单抗治疗的转移性结直肠癌患者的预后标志物。
Ther Adv Med Oncol. 2023 Dec 11;15:17588359231212184. doi: 10.1177/17588359231212184. eCollection 2023.
4
Survival effects of primary and metastatic surgical treatment in metastatic small intestinal tumors: A propensity score-matching study.原发和转移手术治疗对转移性小肠肿瘤的生存影响:倾向评分匹配研究。
PLoS One. 2022 Jun 24;17(6):e0270608. doi: 10.1371/journal.pone.0270608. eCollection 2022.
5
Prognostic Significance of the Immunological Indices in Patients Who Underwent Complete Resection of Pulmonary Metastases of Colorectal Cancer.完全切除结直肠癌肺转移患者免疫指标的预后意义。
In Vivo. 2021 Mar-Apr;35(2):1091-1100. doi: 10.21873/invivo.12354.
6
The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with V600E mutation.格拉斯哥预后评分对携带V600E突变的转移性结直肠癌患者二线化疗生存率的影响。
Ther Adv Med Oncol. 2019 Jan 12;11:1758835918820298. doi: 10.1177/1758835918820298. eCollection 2019.
7
Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients.格拉斯哥预后评分在结直肠癌中的预后价值:对9839例患者的荟萃分析
Cancer Manag Res. 2018 Dec 24;11:229-249. doi: 10.2147/CMAR.S185350. eCollection 2019.
8
Prognostic role of Glasgow prognostic score in patients with colorectal cancer: evidence from population studies.格拉斯哥预后评分在结直肠癌患者中的预后作用:来自人群研究的证据。
Sci Rep. 2017 Jul 21;7(1):6144. doi: 10.1038/s41598-017-06577-2.
9
Prognostic significance of the preoperative lymphocyte-to-monocyte ratio in patients with colorectal cancer.术前淋巴细胞与单核细胞比值在结直肠癌患者中的预后意义
Oncol Lett. 2017 Feb;13(2):1000-1006. doi: 10.3892/ol.2016.5487. Epub 2016 Dec 12.
10
Inflammation-based prognostic scores as indicators to select candidates for primary site resection followed by multimodal therapy among colorectal cancer patients with multiple metastases.基于炎症的预后评分作为指标,用于在多发转移的结直肠癌患者中选择先进行原发灶切除然后接受多模式治疗的候选者。
Int J Clin Oncol. 2017 Aug;22(4):758-766. doi: 10.1007/s10147-017-1113-2. Epub 2017 Mar 15.